| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Boot Barn Holdings (BOOT) | J.P. Morgan/ Piper Jaffray/ Jefferies | $86.25 | n.a. | |||
| Columbia Pipeline Partners LP (CPPL) | Barclays/ Citigroup | $800.00 | n.a. | |||
| Costamare Partners LP (CMRP) | Morgan Stanley/ Barclays/ Citigroup/ Wells Fargo Securities/ Credit Suisse/ J.P. Morgan | $100.00 | n.a. | |||
| eHi Car Services Ltd (EHIC) | J.P. Morgan/ Goldman Sachs (Asia)/ Deutsche Bank Securities | $100.00 | n.a. | |||
| FibroGen (TBA) | Goldman Sachs/ Citigroup/ Leerink Partners | $125.00 | n.a. | |||
| Kimree (KREE) | Citigroup | $125.00 | n.a. | |||
| Nevro (NVRO) | J.P. Morgan/ Morgan Stanley | $115.00 | n.a. | |||
| PennTex Midstream Partners, LP (PTXP) | Citigroup/ Barclays/ RBC Capital Markets/ Tudor, Pickering, Holt | $150.00 | n.a. | |||
| Radius Bancorp (RADB) | Baird/ Sandler O’Neill + Partners, L.P. | n.a. | n.a. | |||
| S1 Biopharma (SXB) | MLV & Co. LLC | $40.25 | n.a. | |||
| Sutherland Asset Management (SLD) | J.P. Morgan/ Morgan Stanley/ FBR | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| Eyegate Pharmaceuticals (EYEG) | Aegis Capital Corp | 1.92 | $12.00 | $14.00 | $25.00 | 1-Star |
| rEVO Biologics (RBIO) | Piper Jaffray/ Guggenheim Securities | 3.60 | $13.00 | $15.00 | $50.40 | 1-Star |
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Dave & Buster’s Entertainment (PLAY) | Jefferies/ Piper Jaffray | 5.88 | $16.00 | $18.00 | $100.00 | n.a. |
| Dermira (DERM) | Citigroup/ Leerink Partners | 7.81 | $14.00 | $16.00 | $117.19 | n.a. |
| Diplomat Pharmacy (DPLO) | Credit Suisse/ Morgan Stanley/ J.P. Morgan/ Wells Fargo Securities/ William Blair/ Leerink Partners | 13.33 | $14.00 | $16.00 | $200.00 | n.a. |
| EndoStim (STIM) | Wedbush PacGrow Life Sciences | 3.20 | $10.00 | $12.00 | $35.20 | n.a. |
| Great Western Bancorp (GWB) | Deutsche Bank Securities/ BofA Merrill Lynch | 16.00 | $21.00 | $24.00 | $360.00 | n.a. |
| NeuroSigma (NSIG) | Jefferies | 3.57 | $13.00 | $15.00 | $50.00 | n.a. |
| USD Partners LP (USDP ) | Citigroup/ Barclays/ Credit Suisse/ BofA Merrill Lynch | 8.85 | $19.00 | $21.00 | $177.00 | n.a. |
| Vascular Biogenics (VBLX) | Deutsche Bank Securities/ Wells Fargo Securities | 5.40 | $13.00 | $15.00 | $75.60 | n.a. |
| Veritex Holdings (VBTX) | Sandler ONeill + Partners/ Stephens | 2.70 | $12.00 | $14.00 | $35.10 | n.a. |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 29, 2014 | Manager(s) | Offered | Raised | Price | 10/3/14 | Change |
| AAC Holdings (AAC) | William Blair/ Raymond James | 5.00 | $75.00 | $15.00 | $18.65 | 24.33% |
| Yodlee (YDLE) | Goldman Sachs/ Credit Suisse/ BofA Merrill Lynch | 6.25 | $75.00 | $12.00 | $13.44 | 12.00% |
| Wayfair (W) | Goldman Sachs/ BofA Merrill Lynch/ Citigroup | 11.00 | $319.00 | $29.00 | $32.18 | 10.97% |
| Vascular Biogenics (VBLX) | Deutsche Bank Securities/ Wells Fargo Securities | 6.67 | $40.00 | $6.00 | $6.10 | 1.67% |
| DT Asia Investments Ltd (CADTU) (u) | EarlyBirdCapital | 6.00 | $60.00 | $10.00 | $10.00 | 0.00% |
| VWR Corp (VWR) | BofA Merrill Lynch/ Goldman Sach/ J.P. Morgan | 25.53 | $536.17 | $21.00 | $21.00 | 0.00% |
| FMSA (FMSA) | Morgan Stanley/ Wells Fargo Securities/ Barclays | 25.00 | $400.00 | $16.00 | $16.00 | 0.00% |
| AR Capital Acquisition (AUMAU) (u) | Citigroup | 24.00 | $10.00 | $10.00 | $9.82 | -1.80% |
| JP Energy Partners LP (JPEP) | Barclays/ BofA Merrill Lynch | 13.75 | $275.00 | $20.00 | $19.50 | -2.50% |
| Dermira (DERM) | Citigroup/ Leerink Partners | 7.81 | $125.00 | $16.00 | $15.55 | -2.81% |
| Calithera Biosciences (CALA) | Citigroup/ Leerink Partners/ Wells Fargo Securities/ JMP Securities | 8.00 | $80.00 | $10.00 | $9.35 | -6.50% |
| Vivint Solar (VSLR) | Goldman Sachs/ BofA Merrill Lynch/ Credit Suisse | 20.60 | $329.60 | $16.00 | $13.75 | -14.06% |
| Atento S.A. (ATTO) | Morgan Stanley/ Credit Suisse/ Itaú BBA | 10.00 | $150.00 | $15.00 | $12.75 | -15.00% |
